Literature DB >> 10767797

Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation.

W C Chapman1, J P Debelak, C Wright Pinson, M K Washington, J B Atkinson, A Venkatakrishnan, T S Blackwell, J W Christman.   

Abstract

OBJECTIVE: To compare the effects of 35% hepatic cryoablation with a similar degree of radiofrequency ablation (RFA) on lung inflammation, nuclear factor kappaB (NF-kappaB) activation, and production of NF-kappaB dependent cytokines. SUMMARY BACKGROUND DATA: Multisystem injury, including acute lung injury, is a severe complication associated with hepatic cryoablation of 30% to 35% or more of liver parenchyma, but this complication has not been reported with RFA.
METHODS: Sprague-Dawley rats underwent 35% hepatic cryoablation or RFA and were killed at 1, 2, and 6 hours. Liver and lung tissue were freeze-clamped for measurement of NF-kappaB activation, which was detected by electrophoretic mobility shift assay. Serum concentrations of tumor necrosis factor alpha and macrophage inflammatory protein 2 were measured by enzyme-linked immunosorbent assay. Histologic studies of pulmonary tissue and electron microscopy of ablated liver tissue were compared among treatment groups.
RESULTS: Histologic lung sections after cryoablation showed multiple foci of perivenular inflammation, with activated lymphocytes, foamy macrophages, and neutrophils. In animals undergoing RFA, inflammatory foci were not present. NF-kappaB activation was detected at 1 hour in both liver and lung tissue samples of animals undergoing cryoablation but not after RFA, and serum cytokine levels were significantly elevated in cryoablation versus RFA animals. Electron microscopy of cryoablation-treated liver tissue demonstrated disruption of the hepatocyte plasma membrane with extension of intact hepatocyte organelles into the space of Disse; RFA-treated liver tissue demonstrated coagulative destruction of hepatocyte organelles within an intact plasma membrane. To determine the stimulus for systemic inflammation, rats treated with cryoablation had either immediate resection of the ablated segment or delayed resection after a 15-minute thawing interval. Immediate resection of the cryoablated liver tissue prevented NF-kappaB activation and lung injury; however, pulmonary inflammatory changes were present when as little as a 15-minute thaw interval preceded hepatic resection.
CONCLUSIONS: Hepatic cryoablation, but not RFA, induces NF-kappaB activation in the nonablated liver and lung and is associated with acute lung injury. Lung inflammation is associated with the thawing phase of cryoablation and may be related to soluble mediator(s) released from the cryoablated tissue. These findings correlate the clinical observation of an increased incidence of multisystem injury, including adult respiratory distress syndrome (ARDS), after cryoablation but not RFA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767797      PMCID: PMC1421063          DOI: 10.1097/00000658-200005000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

Review 1.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

2.  A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues.

Authors:  F Deryckere; F Gannon
Journal:  Biotechniques       Date:  1994-03       Impact factor: 1.993

3.  Radiofrequency ablation: a novel primary and adjunctive ablative technique for hepatic malignancies.

Authors:  D M Rose; D P Allegra; P J Bostick; L J Foshag; A J Bilchik
Journal:  Am Surg       Date:  1999-11       Impact factor: 0.688

4.  Tumor necrosis factor induces adult respiratory distress syndrome in rats.

Authors:  E Ferrari-Baliviera; K Mealy; R J Smith; D W Wilmore
Journal:  Arch Surg       Date:  1989-12

5.  Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production.

Authors:  T S Blackwell; J P Debelak; A Venkatakrishnan; D J Schot; D H Harley; C W Pinson; P Williams; K Washington; J W Christman; W C Chapman
Journal:  Surgery       Date:  1999-09       Impact factor: 3.982

6.  Surgical therapy for recurrent liver metastases from colorectal cancer.

Authors:  M D Stone; B Cady; R L Jenkins; W V McDermott; G D Steele
Journal:  Arch Surg       Date:  1990-06

7.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

Authors:  K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

8.  Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury.

Authors:  S E Goldblum; B Hennig; M Jay; K Yoneda; C J McClain
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Cryoablation of unresectable malignant liver tumors.

Authors:  M Shafir; R Shapiro; M Sung; R Warner; A Sicular; A Klipfel
Journal:  Am J Surg       Date:  1996-01       Impact factor: 2.565

10.  Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man.

Authors:  G J Stewart; A Preketes; M Horton; W B Ross; D L Morris
Journal:  Cryobiology       Date:  1995-06       Impact factor: 2.487

View more
  32 in total

1.  Large volume hepatic microwave ablation elicits fewer pulmonary changes than radiofrequency or cryotherapy.

Authors:  Fateh Ahmad; Gianpiero Gravante; Neil Bhardwaj; Andrew Strickland; Rizwan Basit; Kevin West; Roberto Sorge; Ashley R Dennison; David M Lloyd
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

2.  Incidence of hypercoagulable events after image-guided percutaneous cryoablation of renal tumors: a single-center experience.

Authors:  Jason B Hartman; Nicholas Bhojwani; David J Corn; Matthew M Cooney; John Haaga; Lee Ponsky; Robert Abouassaly; Akshay Paspulati; J David Prologo
Journal:  J Vasc Interv Radiol       Date:  2014-03-18       Impact factor: 3.464

Review 3.  Percutaneous Image-Guided Cryoablation in Vascular Anomalies.

Authors:  Raja Shaikh
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

Review 4.  Percutaneous tumor ablation with radiofrequency.

Authors:  Bradford J Wood; Jeffrey R Ramkaransingh; Tito Fojo; McClellan M Walther; Stephen K Libutti
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

Review 5.  Thermal ablation of tumours: biological mechanisms and advances in therapy.

Authors:  Katrina F Chu; Damian E Dupuy
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

6.  [Cryoablation - back again?].

Authors:  P Isfort; T Penzkofer; A H Mahnken
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

7.  The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death.

Authors:  Christian Beyer; Nancy A Stearns; Adreas Giessl; Jörg H W Distler; Georg Schett; David S Pisetsky
Journal:  Innate Immun       Date:  2012-02-16       Impact factor: 2.680

8.  Complement depletion enhances pulmonary inflammatory response after liver injury.

Authors:  Sean C Glasgow; Sathyabama Kanakasabai; Sabarinathan Ramachandran; T Mohanakumar; William C Chapman
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

Review 9.  Role of interventional radiology in managing pediatric liver tumors : Part 2: percutaneous interventions.

Authors:  C Matthew Hawkins; Alexander J Towbin; Derek J Roebuck; Eric J Monroe; Anne E Gill; Avnesh S Thakor; Richard B Towbin; Anne Marie Cahill; Matthew P Lungren
Journal:  Pediatr Radiol       Date:  2018-02-02

10.  Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma.

Authors:  Tan To Cheung; Sheung Tat Fan; Ferdinand S K Chu; Caroline R Jenkins; Kenneth S H Chok; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; See Ching Chan; Thomas C C Yau; Ronnie T P Poon; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-04       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.